|
|||||||||||||||||||||||||||||||||||||||||||
|
|
Key: Meeting
Showing releases 176-200 out of 941. << < 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 > >>
Public Release: 28-Feb-2013
Human trials for Streptococcus A vaccine Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever. Contact: Helen Wright Public Release: 28-Feb-2013
Wolf in sheep's clothing: Uncovering how deadly bacteria trick the immune system A new UCLA study demonstrates how bacteria can pretend to be a virus and trick the immune system into sending out the wrong type of defense. Such manipulation sheds light on how the flu may make us more susceptible to pneumonia or as in the recent outbreak of TB in Los Angeles, possibly how the flu and other environmental factors could be used to the TB bacteria's advantage. Contact: Rachel Champeau Public Release: 28-Feb-2013
Deworming important for children's health, has limited impact on infection in wider communities Although they have an important impact on children's health and education, school-based deworming programs have a limited impact on the level of infection in the wider community, according to a mathematical modeling study conducted by researchers at Imperial College London. Contact: Sam Wong Public Release: 27-Feb-2013
Rapid, point-of-care tests for syphilis: The future of diagnosis An international research team, led by the Research Institute of the McGill University Health Centre, has demonstrated that rapid and point-of-care tests (POC) for syphilis are as accurate as conventional laboratory tests. The findings, which were published in PLOS ONE, call for a major change in approach to syphilis testing and recommend replacing first line laboratory tests with POC tests globally, especially in resource-limited settings. Contact: Julie Robert Public Release: 27-Feb-2013
New study shows viruses can have immune systems A study published today in Nature reports that a viral predator of the cholera bacteria has stolen the functional immune system of bacteria and is using it against its bacterial host. This provides the first evidence that this type of virus, the bacteriophage, can acquire an adaptive immune system. The study has implications for phage therapy, the use of phages to treat bacterial diseases. Contact: Siobhan Gallagher Public Release: 26-Feb-2013
DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases Today in Madrid, Spain, the Drugs for Neglected Diseases initiative received the BBVA Foundation 'Frontiers of Knowledge and Culture Award for Development Cooperation'. This EUR 400,000 award will be presented at a ceremony in Madrid, Spain, in June of this year. Contact: Violaine Dällenbach Public Release: 26-Feb-2013
Breakthrough camera to improve detection of blinding eye disease and diabetes The world's first intelligent retinal camera will accurately and rapidly detect and eventually diagnose sight-threatening conditions such as diabetic retinopathy and glaucoma. The camera is being designed for ease of use in the most extreme environments so that it can be used by technical support staff and in the most remote and under-served locations, especially to close the gap in eye health in Australian Aboriginal communities. Contact: Stephen Davis Public Release: 26-Feb-2013
Over a million pregnant women infected with syphilis world-wide Syphilis still affects large numbers of pregnant women world-wide, causing serious health problems and even death to their babies, yet this infection could be prevented by early testing and treatment, according to a study by international researchers published in this week's PLOS Medicine. Contact: Sumrina Yousufzai Public Release: 26-Feb-2013
US budget cuts could jeopardize development of life-saving tools against major killers Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives. Contact: Katy Lenard Public Release: 25-Feb-2013
Putting malaria on the SHELPH Experts have disabled a unique member of the signalling proteins which are essential for the development of the malaria parasite. They have produced a mutant lacking the ancient bacterial Shewanella-like protein phosphatase known as SHLP1 (pronounced shelph). This mutant is unable to complete its complex life cycle and is arrested in its development in the mosquito. Contact: Lindsay Brooke Public Release: 25-Feb-2013
Scientists' findings disclose a new and much needed test for river blindness infection Scientists at the Scripps Research Institute have found a telltale molecular marker for onchocerciasis or "river blindness," a parasitic infection that affects tens of millions of people in Africa, Latin America and other tropical regions. The newly discovered biomarker, detectable in patients' urine, is secreted by Onchocerca volvulus worms during an active infection. The biomarker could form the basis of a portable, field-ready test with significant advantages over current diagnostic methods. Contact: Mika Ono Public Release: 21-Feb-2013
Same-sex attracted men neglected in Africa HIV-related research and programming has excluded same-sex attracted men in Africa for three decades. Their exclusion cannot be accounted for by the assertion that they are unreachable, says Norwegian researcher. Contact: Thomas Keilman Public Release: 21-Feb-2013
Scale-up of HIV treatment in rural South Africa dramatically increases adult life expectancy The large antiretroviral treatment scale-up in a rural community in KwaZulu-Natal, South Africa, has led to a rapid and dramatic increase in population adult life expectancy. Contact: Todd Datz Public Release: 21-Feb-2013
Research suggests malaria can be defeated without a globally led eradication program Malaria does not have to be eradicated globally for individual countries to succeed at maintaining elimination of the disease, according to research from the University of Florida's Emerging Pathogens Institute and department of geography, to be published in the journal Science Feb. 22. Contact: Andrew Tatem Public Release: 20-Feb-2013
Handheld device for detecting counterfeit and substandard medicines tested by PQM Device may perform well detecting counterfeits; not suited to identifying substandard medicines. Contact: Claudia Costabile Public Release: 20-Feb-2013
Creeping epidemic of obesity hits Asia Pacific region Over eating, sedentary lifestyles, cultural attitudes, and lack of prevention programs are to blame for the rising epidemic of obesity in the Asia Pacific region. Overweight and obesity has quadrupled in China and societies still label people of healthy weight as poor. Prevention will be an important theme at the 19th Asian Pacific Congress of Cardiology held Feb. 21-24, 2013 in Pattaya, Thailand. Contact: Jacqueline Partarrieu Public Release: 19-Feb-2013
New approach alters malaria maps Identifying areas of malarial infection risk depends more on daily temperature variation than on the average monthly temperatures, according to a team of researchers, who believe that their results may also apply to environmentally temperature-dependent organisms other than the malaria parasite. Contact: A'ndrea Elyse Messer Public Release: 19-Feb-2013
Engineering control theory helps create dynamic brain models Models of the human brain, patterned on engineering control theory, may some day help researchers control such neurological diseases as epilepsy, Parkinson's and migraines, according to a Penn State researcher who is using mathematical models of neuron networks from which more complex brain models emerge. Contact: A'ndrea Elyse Messer Public Release: 19-Feb-2013
Virology researcher awarded nearly $2 million to study chronic hepatitis E A Virginia-Maryland Regional College of Veterinary Medicine scientist has been awarded nearly $2 million from the National Institutes of Health to better understand chronic hepatitis E virus by focusing on patients with chronic infections. The project seeks to develop a chronic hepatitis E model to study how and why the disease progresses into chronicity and its possible medical prevention and treatment. Contact: Sherrie R. Whaley Public Release: 19-Feb-2013
Age-related macular degeneration common cause of vision impairment in Kenya Despite current beliefs, the degenerative eye condition age-related macular degeneration is a common cause of vision impairment and blindness in sub-Saharan Africa, requiring an urgent review of vision services, according to a study by international researchers published in this week's PLOS Medicine. Contact: Sumrina Yousufzai Public Release: 18-Feb-2013
Young malaria parasites refuse to take their medicine, may explain emerging drug resistance New research has revealed that immature malaria parasites are more resistant to treatment with key antimalarial drugs than older parasites, a finding that could lead to more effective treatments for a disease that kills one person every minute and is developing resistance to drugs at an alarming rate. Contact: Nerissa Hannink Public Release: 17-Feb-2013
Diamond sheds light on basic building blocks of life The UK's national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 – including serious viruses such as those responsible for AIDS, Hepatitis and some types of flu – can be analyzed at atomic and molecular level using synchrotron light. Studying pathogens in this way has the potential to open up new paths for the development of therapeutic treatments and vaccines. Contact: Isabelle Boscaro-Clarke Public Release: 15-Feb-2013
MSU launches groundbreaking drug trial in Africa Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy each year. Contact: Andy McGlashen Public Release: 15-Feb-2013
DNDi Latin America receives 2013 Carlos Slim Health Award The Drugs for Neglected Diseases initiative in Latin America received the 2013 Carlos Slim Health Award in recognition of 10 years of exceptional work in research and development to deliver new, life-saving treatments for neglected patients. Contact: Betina Moura Public Release: 14-Feb-2013
New methodology to predict pandemics EcoHealth Alliance, the nonprofit organization that focuses on local conservation and global health issues, announced new research focused on the rapid identification of disease outbreaks in the peer reviewed publication, Journal of the Royal Society Interface. Contact: Anthony M. Ramos
Showing releases 176-200 out of 941. << < 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 > >>
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||